STOCKS TO WATCH: SYNERGY PHARMACEUTICALS INC. (SGYP) AND TWILIO INC. (TWLO) IN THE SPOTLIGHT

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) recorded 150.4% uptrend from the beginning of this year till date. The 12-month potential price target for Synergy Pharmaceuticals Inc. is set at $2. This target means that the stock has an upside potential to increase by 589.66% from the current trading price. The stock of SGYP went up by $0.05 now trading at $0.29. Their shares witnessed a 314.29% increase from the 52-week low price of $0.07 they recorded on 2018-12-26. Even though it is still -865.52% behind the $2.8 high touched on 2018-01-25. The last few days have been good for the stock, as its price has grew by 24% during the week. It has also performed poorly over the past three months, as it lost around -80.73% while it has so far retreated around -87.38% during the course of a year.

When giving their opinion, around 33.33% of Wall Street analysts, which represents 1 out of 3 rated the stock as a Buy. 2 brokerage firms of the remaining 66.67% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate SGYP shares held by institutional investors represents 38.7% of total shares. 16 institutions entered new Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) positions, 46 added to their existing positions in these shares, 61 lowered their positions, and 24 exited their positions entirely.

Synergy Pharmaceuticals Inc. (SGYP) trade volume has increased by 5.51% as around 14,780,663 shares were sold when compared with its 50-day average volume of traded shares which is 14,009,254. At the moment, SGYP is witnessing a uptrend, as it is trading 65.59% above its 20-day SMA, 0.74% above its 50-day SMA, and -78.52% above its 200-day SMA. The company runs an ROE of roughly 267.8%, with financial analysts predicting that their earnings per share growth will be around 0% per annum for the next five year. This will be compared to the -9.3% decrease witnessed over the past five years.

The first technical resistance point for Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) will likely come at $0.31, marking a 6.45% premium to the current level. The second resistance point is at $0.33, about 12.12% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $0.21, the lower end of the range. SGYP’s 14-day MACD is 0.03 and this positive figure indicates an upward trading trend. The company’s 14-day RSI (relative strength index) score is 55.53, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 322.52 percent, which is high when compared to that of the 50-day’s 316.26 percent.

The shares of Twilio Inc. (NYSE:TWLO) has increased by 2.14%, and now trading at $102.11 on the Wall Street in the intra-day deal, with their shares traded now around 4,626,549. This is a decline of -915,249 shares over the average 5,541,798 shares that were traded daily over the last three months. The stock that is trading at $102.11 went higher by 339.18% from its 52-week low of $23.25 that it attained back on 2018-02-09. The stock recorded a 52-week high of $104.12 nearly 1 days ago on 2019-01-17.

TWLO stock has performed well over the past 30 days, as it added 16.76% while its price climbed by 14.34% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 6.14% over the last week. The stock’s 12-month potential target price is now at $95.74. This means that the stock price might likely increase by -6.24% from its current trading price.18 out of 18 Wall Street analysts which represents 100% rated the stock as a buy while the remaining 0 rated it as a hold, with 0 of analysts rating it as a sell.

Twilio Inc. (NYSE:TWLO) has been utilizing an ROE that is roughly -23.6%, with stock analysts predicting that the company’s EPS for the next five years will go up by 8% per year, following the 0% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 14.07% above its 20-day SMA, 15.79% above its 50-day SMA, and 46.96% above its 200-day SMA. In percentage terms, the aggregate Twilio Inc. shares held by institutional investors is 75.6%. 83 institutions jumped in to acquire Twilio Inc. (TWLO) fresh stake, 168 added to their current holdings in these shares, 141 lowered their positions, and 28 left no stake in the company.

The stock’s 9-day MACD is 2.59 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 69.52, which shows that its stock has been overbought. The 20-day historical volatility for the shares stand at 63.18 percent, which is less when compared to that of the 50-day’s 103.54 percent. On the daily chart, we see that the stock could reach the first level of resistance at $104.41, sporting a 2.2% premium to the current level. The next resistance point is at $106.71, representing nearly 4.31% premium to the current market price of Twilio Inc. (TWLO). On the other hand, failure to breach the immediate hurdles can drag it down to $96.93, the lower end of the range.

error: Content is protected !!